Your Title Goes Here
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
IMPROVE AVAILABILITY
Faster Availability with INTERCEPT Platelets
Potentially receive platelets sooner and ready for transfusion with the avoidance of bacterial testing and product holds.2,3
PROTECT PATIENTS*
Proven Safety and Efficacy
Help protect patients with proactive broad-spectrum reduction of transfusion-transmitted infection (TTI) risk and transfusion-associated graft-vs-host disease (TA-GVHD) risk, through the inactivation of bacteria, viruses, parasites, and leukocytes.1
Blood collected from donors is the only supply available to patients in need
Also, with PR platelets, the need for irradiation prior to issue is no longer present. This allows us to distribute platelets more quickly to patients in need.
Dr. Shannon Walker, MD
Assistant Professor, Transfusion Medicine & Pediatric Hematology/Oncology
Department of Pathology, Microbiology & Immunology and Pediatrics
Vanderbilt University Medical Center
